nodes	percent_of_prediction	percent_of_DWPC	metapath
Promazine—Tamoxifen—breast cancer	0.435	1	CrCtD
Promazine—CYP3A4—breast cancer	0.0456	1	CbGaD
Promazine—Tamoxifen—Toremifene—breast cancer	0.0322	0.117	CrCrCtD
Promazine—Doxylamine—Toremifene—breast cancer	0.0269	0.0978	CrCrCtD
Promazine—Bromodiphenhydramine—Toremifene—breast cancer	0.0227	0.0827	CrCrCtD
Promazine—Clofedanol—Toremifene—breast cancer	0.0185	0.0672	CrCrCtD
Promazine—Cyclobenzaprine—Tamoxifen—breast cancer	0.0184	0.0668	CrCrCtD
Promazine—Orphenadrine—Toremifene—breast cancer	0.0179	0.065	CrCrCtD
Promazine—Benzphetamine—Toremifene—breast cancer	0.0179	0.065	CrCrCtD
Promazine—Doxylamine—Tamoxifen—breast cancer	0.0169	0.0614	CrCrCtD
Promazine—Diphenhydramine—Toremifene—breast cancer	0.0159	0.0577	CrCrCtD
Promazine—CYP1A2—Anastrozole—breast cancer	0.0157	0.087	CbGbCtD
Promazine—Tripelennamine—Tamoxifen—breast cancer	0.0153	0.0556	CrCrCtD
Promazine—CYP1A2—Toremifene—breast cancer	0.0143	0.0795	CbGbCtD
Promazine—Bromodiphenhydramine—Tamoxifen—breast cancer	0.0143	0.0519	CrCrCtD
Promazine—Dimetacrine—Tamoxifen—breast cancer	0.0143	0.0519	CrCrCtD
Promazine—CYP2C9—Anastrozole—breast cancer	0.0141	0.0783	CbGbCtD
Promazine—Clofedanol—Tamoxifen—breast cancer	0.0116	0.0422	CrCrCtD
Promazine—CYP2C19—Lapatinib—breast cancer	0.0113	0.0629	CbGbCtD
Promazine—Orphenadrine—Tamoxifen—breast cancer	0.0112	0.0408	CrCrCtD
Promazine—Benzphetamine—Tamoxifen—breast cancer	0.0112	0.0408	CrCrCtD
Promazine—CYP3A4—Exemestane—breast cancer	0.0108	0.0601	CbGbCtD
Promazine—CYP2C9—Idarubicin—breast cancer	0.0107	0.0594	CbGbCtD
Promazine—Diphenhydramine—Tamoxifen—breast cancer	0.00997	0.0362	CrCrCtD
Promazine—CYP3A4—Letrozole—breast cancer	0.00922	0.0511	CbGbCtD
Promazine—CYP3A4—Anastrozole—breast cancer	0.00821	0.0456	CbGbCtD
Promazine—CYP3A4—Toremifene—breast cancer	0.00751	0.0417	CbGbCtD
Promazine—CYP3A4—Fulvestrant—breast cancer	0.00698	0.0387	CbGbCtD
Promazine—CYP3A4—Thiotepa—breast cancer	0.00622	0.0345	CbGbCtD
Promazine—CYP2C9—Capecitabine—breast cancer	0.00587	0.0325	CbGbCtD
Promazine—CYP3A4—Ixabepilone—breast cancer	0.00569	0.0316	CbGbCtD
Promazine—CYP2C19—Tamoxifen—breast cancer	0.00568	0.0315	CbGbCtD
Promazine—CYP3A4—Lapatinib—breast cancer	0.00548	0.0304	CbGbCtD
Promazine—CYP1A2—Tamoxifen—breast cancer	0.00524	0.0291	CbGbCtD
Promazine—CYP2C9—Tamoxifen—breast cancer	0.00472	0.0262	CbGbCtD
Promazine—CYP3A4—Raloxifene—breast cancer	0.00415	0.023	CbGbCtD
Promazine—CYP1A2—Fluorouracil—breast cancer	0.00386	0.0214	CbGbCtD
Promazine—CYP2C9—Paclitaxel—breast cancer	0.00367	0.0204	CbGbCtD
Promazine—CYP2C9—Fluorouracil—breast cancer	0.00348	0.0193	CbGbCtD
Promazine—CYP3A4—Vinorelbine—breast cancer	0.00304	0.0169	CbGbCtD
Promazine—CYP3A4—Tamoxifen—breast cancer	0.00274	0.0152	CbGbCtD
Promazine—CYP3A4—Mitoxantrone—breast cancer	0.00268	0.0148	CbGbCtD
Promazine—CYP3A4—Paclitaxel—breast cancer	0.00214	0.0118	CbGbCtD
Promazine—CYP3A4—Irinotecan—breast cancer	0.00211	0.0117	CbGbCtD
Promazine—CYP3A4—Vinblastine—breast cancer	0.00187	0.0104	CbGbCtD
Promazine—CYP3A4—Docetaxel—breast cancer	0.00154	0.00856	CbGbCtD
Promazine—CHRM3—muscle of abdomen—breast cancer	0.00144	0.186	CbGeAlD
Promazine—CYP3A4—Doxorubicin—breast cancer	0.00115	0.00638	CbGbCtD
Promazine—CHRM5—epithelium—breast cancer	0.000307	0.0397	CbGeAlD
Promazine—CHRM5—skin of body—breast cancer	0.000292	0.0378	CbGeAlD
Promazine—ADRA1D—epithelium—breast cancer	0.000274	0.0355	CbGeAlD
Promazine—Trifluoperazine—S100A4—breast cancer	0.000241	0.0996	CrCbGaD
Promazine—CYP2C9—mammary gland—breast cancer	0.000222	0.0287	CbGeAlD
Promazine—Tamoxifen—ESRRA—breast cancer	0.000206	0.0853	CrCbGaD
Promazine—ADRA1D—female reproductive system—breast cancer	0.000204	0.0264	CbGeAlD
Promazine—CYP1A2—nipple—breast cancer	0.000193	0.025	CbGeAlD
Promazine—HRH1—nipple—breast cancer	0.000181	0.0234	CbGeAlD
Promazine—ADRA2A—nipple—breast cancer	0.000178	0.023	CbGeAlD
Promazine—ADRA1D—endocrine gland—breast cancer	0.000172	0.0223	CbGeAlD
Promazine—Dimetacrine—ACHE—breast cancer	0.000166	0.0686	CrCbGaD
Promazine—ADRA1A—epithelium—breast cancer	0.000157	0.0204	CbGeAlD
Promazine—Tamoxifen—SULT1A1—breast cancer	0.000156	0.0646	CrCbGaD
Promazine—HTR2C—female reproductive system—breast cancer	0.000151	0.0195	CbGeAlD
Promazine—CHRM1—female reproductive system—breast cancer	0.000142	0.0184	CbGeAlD
Promazine—CHRM3—adipose tissue—breast cancer	0.000139	0.0179	CbGeAlD
Promazine—CHRM2—endocrine gland—breast cancer	0.000132	0.0171	CbGeAlD
Promazine—CHRM3—female reproductive system—breast cancer	0.000127	0.0165	CbGeAlD
Promazine—ADRA1A—adipose tissue—breast cancer	0.000127	0.0165	CbGeAlD
Promazine—DRD2—pituitary gland—breast cancer	0.000125	0.0162	CbGeAlD
Promazine—HTR2A—embryo—breast cancer	0.000125	0.0161	CbGeAlD
Promazine—HRH1—epithelium—breast cancer	0.000122	0.0158	CbGeAlD
Promazine—CHRM1—endocrine gland—breast cancer	0.00012	0.0156	CbGeAlD
Promazine—CHRM3—female gonad—breast cancer	0.000116	0.015	CbGeAlD
Promazine—ADRA1A—adrenal gland—breast cancer	0.000114	0.0148	CbGeAlD
Promazine—HRH1—endometrium—breast cancer	0.000109	0.0141	CbGeAlD
Promazine—CHRM3—endocrine gland—breast cancer	0.000108	0.014	CbGeAlD
Promazine—ADRA2A—endometrium—breast cancer	0.000107	0.0139	CbGeAlD
Promazine—HTR2A—epithelium—breast cancer	0.000102	0.0132	CbGeAlD
Promazine—CYP2C19—endocrine gland—breast cancer	0.0001	0.013	CbGeAlD
Promazine—ADRA1A—endocrine gland—breast cancer	9.9e-05	0.0128	CbGeAlD
Promazine—ADRA2A—uterus—breast cancer	9.89e-05	0.0128	CbGeAlD
Promazine—HRH1—adipose tissue—breast cancer	9.85e-05	0.0127	CbGeAlD
Promazine—ADRA2A—pituitary gland—breast cancer	9.72e-05	0.0126	CbGeAlD
Promazine—DRD2—endocrine gland—breast cancer	9.7e-05	0.0126	CbGeAlD
Promazine—ADRA2A—adipose tissue—breast cancer	9.68e-05	0.0125	CbGeAlD
Promazine—CYP2C9—female reproductive system—breast cancer	9.18e-05	0.0119	CbGeAlD
Promazine—HRH1—female reproductive system—breast cancer	9.05e-05	0.0117	CbGeAlD
Promazine—ADRA2A—female reproductive system—breast cancer	8.89e-05	0.0115	CbGeAlD
Promazine—HRH1—adrenal gland—breast cancer	8.84e-05	0.0114	CbGeAlD
Promazine—ADRA2A—adrenal gland—breast cancer	8.68e-05	0.0112	CbGeAlD
Promazine—HTR2A—pituitary gland—breast cancer	8.26e-05	0.0107	CbGeAlD
Promazine—HRH1—female gonad—breast cancer	8.24e-05	0.0107	CbGeAlD
Promazine—CYP1A2—endocrine gland—breast cancer	8.18e-05	0.0106	CbGeAlD
Promazine—ADRA2A—female gonad—breast cancer	8.09e-05	0.0105	CbGeAlD
Promazine—CYP2C9—endocrine gland—breast cancer	7.77e-05	0.0101	CbGeAlD
Promazine—HRH1—endocrine gland—breast cancer	7.66e-05	0.00992	CbGeAlD
Promazine—HTR2A—female reproductive system—breast cancer	7.56e-05	0.00979	CbGeAlD
Promazine—ADRA2A—endocrine gland—breast cancer	7.53e-05	0.00974	CbGeAlD
Promazine—HTR2A—adrenal gland—breast cancer	7.38e-05	0.00955	CbGeAlD
Promazine—CYP3A4—female reproductive system—breast cancer	7e-05	0.00906	CbGeAlD
Promazine—HTR2A—endocrine gland—breast cancer	6.4e-05	0.00828	CbGeAlD
Promazine—CYP3A4—endocrine gland—breast cancer	5.92e-05	0.00767	CbGeAlD
Promazine—Ethopropazine—BCHE—breast cancer	5.8e-05	0.024	CrCbGaD
Promazine—HRH1—lymph node—breast cancer	5.3e-05	0.00685	CbGeAlD
Promazine—ADRA2A—lymph node—breast cancer	5.2e-05	0.00673	CbGeAlD
Promazine—Orphenadrine—SCN10A—breast cancer	5.1e-05	0.0211	CrCbGaD
Promazine—Clomipramine—GSTP1—breast cancer	4.87e-05	0.0201	CrCbGaD
Promazine—Triflupromazine—BCHE—breast cancer	4.75e-05	0.0196	CrCbGaD
Promazine—Tamoxifen—ESR2—breast cancer	4.4e-05	0.0182	CrCbGaD
Promazine—Tripelennamine—CYP2D6—breast cancer	4.2e-05	0.0173	CrCbGaD
Promazine—Tamoxifen—CYP1B1—breast cancer	4.01e-05	0.0166	CrCbGaD
Promazine—Cyclobenzaprine—CYP2D6—breast cancer	3.49e-05	0.0144	CrCbGaD
Promazine—Mequitazine—CYP2D6—breast cancer	3.26e-05	0.0135	CrCbGaD
Promazine—Alimemazine—CYP3A4—breast cancer	3.25e-05	0.0134	CrCbGaD
Promazine—Cyclobenzaprine—CYP3A4—breast cancer	2.99e-05	0.0124	CrCbGaD
Promazine—Tamoxifen—CYP19A1—breast cancer	2.94e-05	0.0122	CrCbGaD
Promazine—Diltiazem—CYP2D6—breast cancer	2.92e-05	0.0121	CrCbGaD
Promazine—Mequitazine—CYP3A4—breast cancer	2.8e-05	0.0116	CrCbGaD
Promazine—Tamoxifen—ABCG2—breast cancer	2.77e-05	0.0114	CrCbGaD
Promazine—Oxcarbazepine—CYP3A4—breast cancer	2.74e-05	0.0113	CrCbGaD
Promazine—Tamoxifen—ESR1—breast cancer	2.71e-05	0.0112	CrCbGaD
Promazine—Diltiazem—CYP3A4—breast cancer	2.51e-05	0.0104	CrCbGaD
Promazine—Brompheniramine—CYP2D6—breast cancer	2.49e-05	0.0103	CrCbGaD
Promazine—Chlorphenamine—CYP2D6—breast cancer	2.44e-05	0.0101	CrCbGaD
Promazine—Diphenhydramine—PTGS1—breast cancer	2.43e-05	0.0101	CrCbGaD
Promazine—Oxcarbazepine—ALB—breast cancer	2.39e-05	0.00986	CrCbGaD
Promazine—Pipotiazine—CYP2D6—breast cancer	2.32e-05	0.00958	CrCbGaD
Promazine—Chlorpromazine—BCHE—breast cancer	2.29e-05	0.00947	CrCbGaD
Promazine—Mesoridazine—CYP2D6—breast cancer	2.29e-05	0.00945	CrCbGaD
Promazine—Prochlorperazine—CYP2D6—breast cancer	2.22e-05	0.00915	CrCbGaD
Promazine—Tamoxifen—CYP1A1—breast cancer	2.17e-05	0.00895	CrCbGaD
Promazine—Brompheniramine—CYP3A4—breast cancer	2.13e-05	0.00881	CrCbGaD
Promazine—Chlorphenamine—CYP3A4—breast cancer	2.09e-05	0.00865	CrCbGaD
Promazine—Diltiazem—ABCB1—breast cancer	2.09e-05	0.00863	CrCbGaD
Promazine—Fluphenazine—CYP2D6—breast cancer	2e-05	0.00828	CrCbGaD
Promazine—Pipotiazine—CYP3A4—breast cancer	1.99e-05	0.00822	CrCbGaD
Promazine—Prochlorperazine—CYP3A4—breast cancer	1.9e-05	0.00785	CrCbGaD
Promazine—Carbamazepine—CYP3A4—breast cancer	1.87e-05	0.00771	CrCbGaD
Promazine—Triflupromazine—ABCB1—breast cancer	1.86e-05	0.00769	CrCbGaD
Promazine—Clomipramine—CYP2D6—breast cancer	1.83e-05	0.00757	CrCbGaD
Promazine—Acepromazine—ALB—breast cancer	1.8e-05	0.00745	CrCbGaD
Promazine—Benzphetamine—CYP3A4—breast cancer	1.77e-05	0.00732	CrCbGaD
Promazine—Thioproperazine—ALB—breast cancer	1.76e-05	0.00729	CrCbGaD
Promazine—Pipotiazine—ALB—breast cancer	1.73e-05	0.00717	CrCbGaD
Promazine—Thioridazine—CYP2D6—breast cancer	1.73e-05	0.00713	CrCbGaD
Promazine—Trimipramine—CYP2D6—breast cancer	1.69e-05	0.00697	CrCbGaD
Promazine—Diphenhydramine—CYP2D6—breast cancer	1.66e-05	0.00684	CrCbGaD
Promazine—Methotrimeprazine—CYP2D6—breast cancer	1.65e-05	0.00681	CrCbGaD
Promazine—Promethazine—CYP2D6—breast cancer	1.62e-05	0.00671	CrCbGaD
Promazine—Tamoxifen—CYP2D6—breast cancer	1.61e-05	0.00666	CrCbGaD
Promazine—Doxepin—CYP2D6—breast cancer	1.61e-05	0.00664	CrCbGaD
Promazine—Perphenazine—CYP2D6—breast cancer	1.58e-05	0.00655	CrCbGaD
Promazine—Clomipramine—CYP3A4—breast cancer	1.57e-05	0.0065	CrCbGaD
Promazine—Quetiapine—CYP2D6—breast cancer	1.55e-05	0.00642	CrCbGaD
Promazine—Carbamazepine—ABCB1—breast cancer	1.55e-05	0.00642	CrCbGaD
Promazine—Desipramine—CYP2D6—breast cancer	1.47e-05	0.00609	CrCbGaD
Promazine—Trimipramine—CYP3A4—breast cancer	1.45e-05	0.00598	CrCbGaD
Promazine—Fluphenazine—ABCB1—breast cancer	1.43e-05	0.00591	CrCbGaD
Promazine—Tamoxifen—CYP3A4—breast cancer	1.38e-05	0.00571	CrCbGaD
Promazine—Doxepin—CYP3A4—breast cancer	1.38e-05	0.0057	CrCbGaD
Promazine—Clomipramine—ALB—breast cancer	1.37e-05	0.00567	CrCbGaD
Promazine—Perphenazine—CYP3A4—breast cancer	1.36e-05	0.00562	CrCbGaD
Promazine—Orphenadrine—CYP3A4—breast cancer	1.34e-05	0.00555	CrCbGaD
Promazine—Quetiapine—CYP3A4—breast cancer	1.33e-05	0.00551	CrCbGaD
Promazine—Clomipramine—ABCB1—breast cancer	1.31e-05	0.00541	CrCbGaD
Promazine—Chlorprothixene—ABCB1—breast cancer	1.3e-05	0.00538	CrCbGaD
Promazine—Desipramine—CYP3A4—breast cancer	1.26e-05	0.00523	CrCbGaD
Promazine—Chlorpromazine—CYP2D6—breast cancer	1.26e-05	0.00519	CrCbGaD
Promazine—Imipramine—CYP2D6—breast cancer	1.25e-05	0.00517	CrCbGaD
Promazine—Amitriptyline—CYP2D6—breast cancer	1.24e-05	0.00513	CrCbGaD
Promazine—Trimipramine—ABCB1—breast cancer	1.2e-05	0.00498	CrCbGaD
Promazine—Promethazine—ABCB1—breast cancer	1.16e-05	0.00479	CrCbGaD
Promazine—Tamoxifen—ABCB1—breast cancer	1.15e-05	0.00476	CrCbGaD
Promazine—Doxepin—ABCB1—breast cancer	1.15e-05	0.00474	CrCbGaD
Promazine—Trifluoperazine—ABCB1—breast cancer	1.14e-05	0.00473	CrCbGaD
Promazine—Quetiapine—ABCB1—breast cancer	1.11e-05	0.00458	CrCbGaD
Promazine—Chlorpromazine—CYP3A4—breast cancer	1.08e-05	0.00445	CrCbGaD
Promazine—Imipramine—CYP3A4—breast cancer	1.07e-05	0.00443	CrCbGaD
Promazine—Amitriptyline—CYP3A4—breast cancer	1.07e-05	0.0044	CrCbGaD
Promazine—Desipramine—ABCB1—breast cancer	1.05e-05	0.00435	CrCbGaD
Promazine—Chlorpromazine—ALB—breast cancer	9.4e-06	0.00389	CrCbGaD
Promazine—Amitriptyline—ALB—breast cancer	9.3e-06	0.00384	CrCbGaD
Promazine—Chlorpromazine—ABCB1—breast cancer	8.97e-06	0.00371	CrCbGaD
Promazine—Imipramine—ABCB1—breast cancer	8.93e-06	0.00369	CrCbGaD
Promazine—Amitriptyline—ABCB1—breast cancer	8.87e-06	0.00367	CrCbGaD
Promazine—ADRA1A—Signaling Pathways—CCND1—breast cancer	9.19e-07	1.71e-05	CbGpPWpGaD
Promazine—ADRA1A—Signaling Pathways—JUN—breast cancer	9.17e-07	1.71e-05	CbGpPWpGaD
Promazine—CYP3A4—Metabolism—HMOX1—breast cancer	9.16e-07	1.71e-05	CbGpPWpGaD
Promazine—ADRA2A—Signaling Pathways—CXCL8—breast cancer	9.16e-07	1.71e-05	CbGpPWpGaD
Promazine—CYP2C19—Metabolism—ALB—breast cancer	9.15e-07	1.71e-05	CbGpPWpGaD
Promazine—CYP3A4—Metabolism—ITPR1—breast cancer	9.14e-07	1.7e-05	CbGpPWpGaD
Promazine—CHRM2—Signaling Pathways—CTNNB1—breast cancer	9.12e-07	1.7e-05	CbGpPWpGaD
Promazine—CHRM4—Signaling Pathways—TP53—breast cancer	9.12e-07	1.7e-05	CbGpPWpGaD
Promazine—HTR2A—Signaling Pathways—MMP9—breast cancer	9.11e-07	1.7e-05	CbGpPWpGaD
Promazine—ADRA2A—Signaling by GPCR—HRAS—breast cancer	9.1e-07	1.7e-05	CbGpPWpGaD
Promazine—ADRA1A—Signaling Pathways—CTNNB1—breast cancer	9.1e-07	1.7e-05	CbGpPWpGaD
Promazine—HRH1—Signaling Pathways—MMP9—breast cancer	9.09e-07	1.69e-05	CbGpPWpGaD
Promazine—HTR2A—Signaling Pathways—CDKN1A—breast cancer	9.08e-07	1.69e-05	CbGpPWpGaD
Promazine—CHRM1—Signaling Pathways—MMP9—breast cancer	9.06e-07	1.69e-05	CbGpPWpGaD
Promazine—HRH1—Signaling Pathways—CDKN1A—breast cancer	9.06e-07	1.69e-05	CbGpPWpGaD
Promazine—HTR2A—Signaling Pathways—PTEN—breast cancer	9.06e-07	1.69e-05	CbGpPWpGaD
Promazine—HRH1—Signaling Pathways—PTEN—breast cancer	9.04e-07	1.69e-05	CbGpPWpGaD
Promazine—CHRM3—Signaling Pathways—MMP9—breast cancer	9.03e-07	1.68e-05	CbGpPWpGaD
Promazine—CHRM1—Signaling Pathways—CDKN1A—breast cancer	9.03e-07	1.68e-05	CbGpPWpGaD
Promazine—CHRM5—Signaling Pathways—PIK3CA—breast cancer	9.02e-07	1.68e-05	CbGpPWpGaD
Promazine—CYP1A2—Metabolism—CAV1—breast cancer	9.02e-07	1.68e-05	CbGpPWpGaD
Promazine—ADRA1B—Signaling Pathways—VEGFA—breast cancer	9.02e-07	1.68e-05	CbGpPWpGaD
Promazine—CHRM1—Signaling Pathways—PTEN—breast cancer	9.01e-07	1.68e-05	CbGpPWpGaD
Promazine—DRD2—Signaling Pathways—MAPK8—breast cancer	9e-07	1.68e-05	CbGpPWpGaD
Promazine—CHRM3—Signaling Pathways—CDKN1A—breast cancer	9e-07	1.68e-05	CbGpPWpGaD
Promazine—DRD2—Signaling by GPCR—AKT1—breast cancer	8.98e-07	1.67e-05	CbGpPWpGaD
Promazine—CHRM3—Signaling Pathways—PTEN—breast cancer	8.98e-07	1.67e-05	CbGpPWpGaD
Promazine—ADRA2A—Signaling Pathways—CDKN1B—breast cancer	8.95e-07	1.67e-05	CbGpPWpGaD
Promazine—CHRM2—Signaling Pathways—MMP9—breast cancer	8.94e-07	1.67e-05	CbGpPWpGaD
Promazine—ADRA1B—Signaling Pathways—STAT3—breast cancer	8.93e-07	1.66e-05	CbGpPWpGaD
Promazine—ADRA1A—Signaling Pathways—MMP9—breast cancer	8.92e-07	1.66e-05	CbGpPWpGaD
Promazine—CHRM2—Signaling Pathways—CDKN1A—breast cancer	8.91e-07	1.66e-05	CbGpPWpGaD
Promazine—HTR2C—Signaling Pathways—MAPK3—breast cancer	8.91e-07	1.66e-05	CbGpPWpGaD
Promazine—CHRM2—Signaling Pathways—PTEN—breast cancer	8.89e-07	1.66e-05	CbGpPWpGaD
Promazine—ADRA1A—Signaling Pathways—CDKN1A—breast cancer	8.89e-07	1.66e-05	CbGpPWpGaD
Promazine—ADRA1A—Signaling Pathways—PTEN—breast cancer	8.87e-07	1.65e-05	CbGpPWpGaD
Promazine—HTR2A—Signaling Pathways—MAPK8—breast cancer	8.86e-07	1.65e-05	CbGpPWpGaD
Promazine—ADRA2A—GPCR downstream signaling—AKT1—breast cancer	8.85e-07	1.65e-05	CbGpPWpGaD
Promazine—HRH1—Signaling Pathways—MAPK8—breast cancer	8.84e-07	1.65e-05	CbGpPWpGaD
Promazine—DRD4—Signaling Pathways—HRAS—breast cancer	8.84e-07	1.65e-05	CbGpPWpGaD
Promazine—HTR2A—Signaling by GPCR—AKT1—breast cancer	8.83e-07	1.65e-05	CbGpPWpGaD
Promazine—HRH1—Signaling by GPCR—AKT1—breast cancer	8.82e-07	1.64e-05	CbGpPWpGaD
Promazine—CHRM1—Signaling Pathways—MAPK8—breast cancer	8.81e-07	1.64e-05	CbGpPWpGaD
Promazine—CYP3A4—Metabolism—ABCB1—breast cancer	8.79e-07	1.64e-05	CbGpPWpGaD
Promazine—CHRM1—Signaling by GPCR—AKT1—breast cancer	8.79e-07	1.64e-05	CbGpPWpGaD
Promazine—CHRM3—Signaling Pathways—MAPK8—breast cancer	8.78e-07	1.64e-05	CbGpPWpGaD
Promazine—ADRA2A—Signaling Pathways—CASP3—breast cancer	8.77e-07	1.64e-05	CbGpPWpGaD
Promazine—CHRM3—Signaling by GPCR—AKT1—breast cancer	8.76e-07	1.63e-05	CbGpPWpGaD
Promazine—ADRA2A—Signaling Pathways—IL2—breast cancer	8.76e-07	1.63e-05	CbGpPWpGaD
Promazine—CYP2C19—Metabolism—NOS3—breast cancer	8.75e-07	1.63e-05	CbGpPWpGaD
Promazine—CHRM5—Signaling Pathways—TP53—breast cancer	8.73e-07	1.63e-05	CbGpPWpGaD
Promazine—CHRM4—Signaling Pathways—HRAS—breast cancer	8.72e-07	1.63e-05	CbGpPWpGaD
Promazine—ADRA2A—Signaling by GPCR—IL6—breast cancer	8.71e-07	1.62e-05	CbGpPWpGaD
Promazine—CHRM2—Signaling Pathways—MAPK8—breast cancer	8.7e-07	1.62e-05	CbGpPWpGaD
Promazine—CHRM2—Signaling by GPCR—AKT1—breast cancer	8.67e-07	1.62e-05	CbGpPWpGaD
Promazine—ADRA1A—Signaling Pathways—MAPK8—breast cancer	8.67e-07	1.62e-05	CbGpPWpGaD
Promazine—HTR2C—Signaling Pathways—MYC—breast cancer	8.67e-07	1.62e-05	CbGpPWpGaD
Promazine—ADRA1A—Signaling by GPCR—AKT1—breast cancer	8.65e-07	1.61e-05	CbGpPWpGaD
Promazine—HTR2C—Signaling Pathways—TGFB1—breast cancer	8.64e-07	1.61e-05	CbGpPWpGaD
Promazine—CYP3A4—Metabolism—TYMS—breast cancer	8.64e-07	1.61e-05	CbGpPWpGaD
Promazine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—breast cancer	8.62e-07	1.61e-05	CbGpPWpGaD
Promazine—DRD1—Signaling Pathways—PIK3CA—breast cancer	8.6e-07	1.6e-05	CbGpPWpGaD
Promazine—CYP3A4—Metabolism—GSTM1—breast cancer	8.54e-07	1.59e-05	CbGpPWpGaD
Promazine—CYP3A4—Metabolism—NCOR1—breast cancer	8.54e-07	1.59e-05	CbGpPWpGaD
Promazine—CYP3A4—Metabolism—PLA2G4A—breast cancer	8.54e-07	1.59e-05	CbGpPWpGaD
Promazine—ADRA2A—Signaling Pathways—CCND1—breast cancer	8.54e-07	1.59e-05	CbGpPWpGaD
Promazine—DRD2—Signaling Pathways—SRC—breast cancer	8.53e-07	1.59e-05	CbGpPWpGaD
Promazine—ADRA1B—Signaling Pathways—MAPK3—breast cancer	8.53e-07	1.59e-05	CbGpPWpGaD
Promazine—ADRA2A—Signaling Pathways—JUN—breast cancer	8.52e-07	1.59e-05	CbGpPWpGaD
Promazine—ADRA1D—Signaling Pathways—PIK3CA—breast cancer	8.48e-07	1.58e-05	CbGpPWpGaD
Promazine—HTR2C—Signaling Pathways—EGFR—breast cancer	8.48e-07	1.58e-05	CbGpPWpGaD
Promazine—DRD4—Signaling Pathways—IL6—breast cancer	8.46e-07	1.58e-05	CbGpPWpGaD
Promazine—ADRA2A—Signaling Pathways—CTNNB1—breast cancer	8.45e-07	1.58e-05	CbGpPWpGaD
Promazine—CYP2C9—Metabolism—PIK3CD—breast cancer	8.45e-07	1.58e-05	CbGpPWpGaD
Promazine—HTR2A—Signaling Pathways—SRC—breast cancer	8.4e-07	1.57e-05	CbGpPWpGaD
Promazine—HRH1—Signaling Pathways—SRC—breast cancer	8.38e-07	1.56e-05	CbGpPWpGaD
Promazine—CHRM1—Signaling Pathways—SRC—breast cancer	8.35e-07	1.56e-05	CbGpPWpGaD
Promazine—CHRM5—Signaling Pathways—HRAS—breast cancer	8.35e-07	1.56e-05	CbGpPWpGaD
Promazine—CHRM4—Signaling Pathways—IL6—breast cancer	8.34e-07	1.56e-05	CbGpPWpGaD
Promazine—CYP2C9—Metabolism—ALB—breast cancer	8.34e-07	1.56e-05	CbGpPWpGaD
Promazine—CHRM3—Signaling Pathways—SRC—breast cancer	8.33e-07	1.55e-05	CbGpPWpGaD
Promazine—DRD1—Signaling Pathways—TP53—breast cancer	8.32e-07	1.55e-05	CbGpPWpGaD
Promazine—DRD2—Signaling Pathways—VEGFA—breast cancer	8.31e-07	1.55e-05	CbGpPWpGaD
Promazine—ADRA1B—Signaling Pathways—MYC—breast cancer	8.3e-07	1.55e-05	CbGpPWpGaD
Promazine—ADRA2A—Signaling Pathways—MMP9—breast cancer	8.29e-07	1.55e-05	CbGpPWpGaD
Promazine—ADRA1B—Signaling Pathways—TGFB1—breast cancer	8.28e-07	1.54e-05	CbGpPWpGaD
Promazine—ADRA2A—Signaling Pathways—CDKN1A—breast cancer	8.26e-07	1.54e-05	CbGpPWpGaD
Promazine—CHRM2—Signaling Pathways—SRC—breast cancer	8.25e-07	1.54e-05	CbGpPWpGaD
Promazine—ADRA2A—Signaling Pathways—PTEN—breast cancer	8.24e-07	1.54e-05	CbGpPWpGaD
Promazine—DRD2—Signaling Pathways—STAT3—breast cancer	8.23e-07	1.53e-05	CbGpPWpGaD
Promazine—ADRA1A—Signaling Pathways—SRC—breast cancer	8.22e-07	1.53e-05	CbGpPWpGaD
Promazine—CYP1A2—Metabolism—PIK3CG—breast cancer	8.21e-07	1.53e-05	CbGpPWpGaD
Promazine—ADRA1D—Signaling Pathways—TP53—breast cancer	8.21e-07	1.53e-05	CbGpPWpGaD
Promazine—HTR2A—Signaling Pathways—VEGFA—breast cancer	8.18e-07	1.53e-05	CbGpPWpGaD
Promazine—CYP3A4—Metabolism—GPX1—breast cancer	8.18e-07	1.52e-05	CbGpPWpGaD
Promazine—HRH1—Signaling Pathways—VEGFA—breast cancer	8.16e-07	1.52e-05	CbGpPWpGaD
Promazine—CHRM1—Signaling Pathways—VEGFA—breast cancer	8.14e-07	1.52e-05	CbGpPWpGaD
Promazine—ADRA1B—Signaling Pathways—EGFR—breast cancer	8.11e-07	1.51e-05	CbGpPWpGaD
Promazine—CHRM3—Signaling Pathways—VEGFA—breast cancer	8.11e-07	1.51e-05	CbGpPWpGaD
Promazine—HTR2A—Signaling Pathways—STAT3—breast cancer	8.1e-07	1.51e-05	CbGpPWpGaD
Promazine—CYP3A4—Metabolism—CYP1A1—breast cancer	8.09e-07	1.51e-05	CbGpPWpGaD
Promazine—HRH1—Signaling Pathways—STAT3—breast cancer	8.08e-07	1.51e-05	CbGpPWpGaD
Promazine—CYP2C19—Metabolism—PIK3CB—breast cancer	8.08e-07	1.51e-05	CbGpPWpGaD
Promazine—ADRA2A—Signaling Pathways—MAPK8—breast cancer	8.06e-07	1.5e-05	CbGpPWpGaD
Promazine—CHRM1—Signaling Pathways—STAT3—breast cancer	8.06e-07	1.5e-05	CbGpPWpGaD
Promazine—ADRA2A—Signaling by GPCR—AKT1—breast cancer	8.04e-07	1.5e-05	CbGpPWpGaD
Promazine—CHRM2—Signaling Pathways—VEGFA—breast cancer	8.03e-07	1.5e-05	CbGpPWpGaD
Promazine—CHRM3—Signaling Pathways—STAT3—breast cancer	8.03e-07	1.5e-05	CbGpPWpGaD
Promazine—CYP3A4—Metabolism—ERCC2—breast cancer	8.03e-07	1.5e-05	CbGpPWpGaD
Promazine—ADRA1A—Signaling Pathways—VEGFA—breast cancer	8.01e-07	1.49e-05	CbGpPWpGaD
Promazine—HTR2C—Signaling Pathways—KRAS—breast cancer	8.01e-07	1.49e-05	CbGpPWpGaD
Promazine—CYP2C19—Metabolism—PTGS2—breast cancer	8e-07	1.49e-05	CbGpPWpGaD
Promazine—CHRM5—Signaling Pathways—IL6—breast cancer	7.99e-07	1.49e-05	CbGpPWpGaD
Promazine—CYP2C9—Metabolism—NOS3—breast cancer	7.98e-07	1.49e-05	CbGpPWpGaD
Promazine—DRD1—Signaling Pathways—HRAS—breast cancer	7.96e-07	1.48e-05	CbGpPWpGaD
Promazine—CHRM2—Signaling Pathways—STAT3—breast cancer	7.95e-07	1.48e-05	CbGpPWpGaD
Promazine—ADRA1A—Signaling Pathways—STAT3—breast cancer	7.93e-07	1.48e-05	CbGpPWpGaD
Promazine—DRD2—Signaling Pathways—MAPK3—breast cancer	7.86e-07	1.47e-05	CbGpPWpGaD
Promazine—ADRA1D—Signaling Pathways—HRAS—breast cancer	7.85e-07	1.46e-05	CbGpPWpGaD
Promazine—DRD4—Signaling Pathways—AKT1—breast cancer	7.8e-07	1.46e-05	CbGpPWpGaD
Promazine—HTR2A—Signaling Pathways—MAPK3—breast cancer	7.74e-07	1.44e-05	CbGpPWpGaD
Promazine—HRH1—Signaling Pathways—MAPK3—breast cancer	7.72e-07	1.44e-05	CbGpPWpGaD
Promazine—CHRM4—Signaling Pathways—AKT1—breast cancer	7.7e-07	1.44e-05	CbGpPWpGaD
Promazine—CHRM1—Signaling Pathways—MAPK3—breast cancer	7.7e-07	1.44e-05	CbGpPWpGaD
Promazine—CHRM3—Signaling Pathways—MAPK3—breast cancer	7.67e-07	1.43e-05	CbGpPWpGaD
Promazine—ADRA1B—Signaling Pathways—KRAS—breast cancer	7.66e-07	1.43e-05	CbGpPWpGaD
Promazine—DRD2—Signaling Pathways—MYC—breast cancer	7.65e-07	1.43e-05	CbGpPWpGaD
Promazine—ADRA2A—Signaling Pathways—SRC—breast cancer	7.64e-07	1.42e-05	CbGpPWpGaD
Promazine—DRD2—Signaling Pathways—TGFB1—breast cancer	7.63e-07	1.42e-05	CbGpPWpGaD
Promazine—DRD1—Signaling Pathways—IL6—breast cancer	7.61e-07	1.42e-05	CbGpPWpGaD
Promazine—CHRM2—Signaling Pathways—MAPK3—breast cancer	7.6e-07	1.42e-05	CbGpPWpGaD
Promazine—ADRA1A—Signaling Pathways—MAPK3—breast cancer	7.58e-07	1.41e-05	CbGpPWpGaD
Promazine—CHRM3—Metabolism—PIK3CA—breast cancer	7.57e-07	1.41e-05	CbGpPWpGaD
Promazine—CYP3A4—Metabolism—MTHFR—breast cancer	7.55e-07	1.41e-05	CbGpPWpGaD
Promazine—HTR2A—Signaling Pathways—MYC—breast cancer	7.53e-07	1.4e-05	CbGpPWpGaD
Promazine—ADRA1D—Signaling Pathways—IL6—breast cancer	7.51e-07	1.4e-05	CbGpPWpGaD
Promazine—HRH1—Signaling Pathways—MYC—breast cancer	7.51e-07	1.4e-05	CbGpPWpGaD
Promazine—HTR2A—Signaling Pathways—TGFB1—breast cancer	7.51e-07	1.4e-05	CbGpPWpGaD
Promazine—HRH1—Signaling Pathways—TGFB1—breast cancer	7.49e-07	1.4e-05	CbGpPWpGaD
Promazine—CHRM1—Signaling Pathways—MYC—breast cancer	7.48e-07	1.4e-05	CbGpPWpGaD
Promazine—DRD2—Signaling Pathways—EGFR—breast cancer	7.48e-07	1.4e-05	CbGpPWpGaD
Promazine—CHRM1—Signaling Pathways—TGFB1—breast cancer	7.47e-07	1.39e-05	CbGpPWpGaD
Promazine—CHRM3—Signaling Pathways—MYC—breast cancer	7.46e-07	1.39e-05	CbGpPWpGaD
Promazine—CHRM3—Signaling Pathways—TGFB1—breast cancer	7.44e-07	1.39e-05	CbGpPWpGaD
Promazine—ADRA2A—Signaling Pathways—VEGFA—breast cancer	7.44e-07	1.39e-05	CbGpPWpGaD
Promazine—CHRM2—Signaling Pathways—MYC—breast cancer	7.39e-07	1.38e-05	CbGpPWpGaD
Promazine—CHRM5—Signaling Pathways—AKT1—breast cancer	7.37e-07	1.37e-05	CbGpPWpGaD
Promazine—CHRM2—Signaling Pathways—TGFB1—breast cancer	7.37e-07	1.37e-05	CbGpPWpGaD
Promazine—ADRA1A—Signaling Pathways—MYC—breast cancer	7.37e-07	1.37e-05	CbGpPWpGaD
Promazine—ADRA2A—Signaling Pathways—STAT3—breast cancer	7.37e-07	1.37e-05	CbGpPWpGaD
Promazine—CYP2C9—Metabolism—PIK3CB—breast cancer	7.37e-07	1.37e-05	CbGpPWpGaD
Promazine—HTR2A—Signaling Pathways—EGFR—breast cancer	7.36e-07	1.37e-05	CbGpPWpGaD
Promazine—HTR2C—Signaling Pathways—PIK3CA—breast cancer	7.36e-07	1.37e-05	CbGpPWpGaD
Promazine—ADRA1A—Signaling Pathways—TGFB1—breast cancer	7.35e-07	1.37e-05	CbGpPWpGaD
Promazine—HRH1—Signaling Pathways—EGFR—breast cancer	7.34e-07	1.37e-05	CbGpPWpGaD
Promazine—CHRM1—Signaling Pathways—EGFR—breast cancer	7.32e-07	1.37e-05	CbGpPWpGaD
Promazine—CYP2C9—Metabolism—PTGS2—breast cancer	7.3e-07	1.36e-05	CbGpPWpGaD
Promazine—CHRM3—Signaling Pathways—EGFR—breast cancer	7.3e-07	1.36e-05	CbGpPWpGaD
Promazine—CHRM2—Signaling Pathways—EGFR—breast cancer	7.23e-07	1.35e-05	CbGpPWpGaD
Promazine—CYP1A2—Metabolism—PIK3CD—breast cancer	7.22e-07	1.35e-05	CbGpPWpGaD
Promazine—ADRA1A—Signaling Pathways—EGFR—breast cancer	7.21e-07	1.34e-05	CbGpPWpGaD
Promazine—CYP1A2—Metabolism—ALB—breast cancer	7.13e-07	1.33e-05	CbGpPWpGaD
Promazine—HTR2C—Signaling Pathways—TP53—breast cancer	7.12e-07	1.33e-05	CbGpPWpGaD
Promazine—DRD2—Signaling Pathways—KRAS—breast cancer	7.07e-07	1.32e-05	CbGpPWpGaD
Promazine—ADRA1B—Signaling Pathways—PIK3CA—breast cancer	7.04e-07	1.31e-05	CbGpPWpGaD
Promazine—ADRA2A—Signaling Pathways—MAPK3—breast cancer	7.04e-07	1.31e-05	CbGpPWpGaD
Promazine—DRD1—Signaling Pathways—AKT1—breast cancer	7.02e-07	1.31e-05	CbGpPWpGaD
Promazine—CYP2C19—Metabolism—PTEN—breast cancer	6.98e-07	1.3e-05	CbGpPWpGaD
Promazine—CYP3A4—Metabolism—CAV1—breast cancer	6.96e-07	1.3e-05	CbGpPWpGaD
Promazine—HTR2A—Signaling Pathways—KRAS—breast cancer	6.95e-07	1.3e-05	CbGpPWpGaD
Promazine—ADRA2A—Metabolism—PIK3CA—breast cancer	6.95e-07	1.3e-05	CbGpPWpGaD
Promazine—HRH1—Signaling Pathways—KRAS—breast cancer	6.94e-07	1.29e-05	CbGpPWpGaD
Promazine—ADRA1D—Signaling Pathways—AKT1—breast cancer	6.93e-07	1.29e-05	CbGpPWpGaD
Promazine—CHRM1—Signaling Pathways—KRAS—breast cancer	6.92e-07	1.29e-05	CbGpPWpGaD
Promazine—CHRM3—Signaling Pathways—KRAS—breast cancer	6.89e-07	1.29e-05	CbGpPWpGaD
Promazine—ADRA2A—Signaling Pathways—MYC—breast cancer	6.85e-07	1.28e-05	CbGpPWpGaD
Promazine—ADRA2A—Signaling Pathways—TGFB1—breast cancer	6.83e-07	1.27e-05	CbGpPWpGaD
Promazine—CHRM2—Signaling Pathways—KRAS—breast cancer	6.83e-07	1.27e-05	CbGpPWpGaD
Promazine—CYP1A2—Metabolism—NOS3—breast cancer	6.82e-07	1.27e-05	CbGpPWpGaD
Promazine—ADRA1B—Signaling Pathways—TP53—breast cancer	6.81e-07	1.27e-05	CbGpPWpGaD
Promazine—ADRA1A—Signaling Pathways—KRAS—breast cancer	6.81e-07	1.27e-05	CbGpPWpGaD
Promazine—HTR2C—Signaling Pathways—HRAS—breast cancer	6.81e-07	1.27e-05	CbGpPWpGaD
Promazine—ADRA2A—Signaling Pathways—EGFR—breast cancer	6.7e-07	1.25e-05	CbGpPWpGaD
Promazine—ADRA1B—Signaling Pathways—HRAS—breast cancer	6.52e-07	1.21e-05	CbGpPWpGaD
Promazine—HTR2C—Signaling Pathways—IL6—breast cancer	6.51e-07	1.21e-05	CbGpPWpGaD
Promazine—DRD2—Signaling Pathways—PIK3CA—breast cancer	6.49e-07	1.21e-05	CbGpPWpGaD
Promazine—HTR2A—Signaling Pathways—PIK3CA—breast cancer	6.39e-07	1.19e-05	CbGpPWpGaD
Promazine—HRH1—Signaling Pathways—PIK3CA—breast cancer	6.37e-07	1.19e-05	CbGpPWpGaD
Promazine—CYP2C9—Metabolism—PTEN—breast cancer	6.36e-07	1.19e-05	CbGpPWpGaD
Promazine—CHRM1—Signaling Pathways—PIK3CA—breast cancer	6.35e-07	1.18e-05	CbGpPWpGaD
Promazine—CYP3A4—Metabolism—PIK3CG—breast cancer	6.34e-07	1.18e-05	CbGpPWpGaD
Promazine—CHRM3—Signaling Pathways—PIK3CA—breast cancer	6.33e-07	1.18e-05	CbGpPWpGaD
Promazine—ADRA2A—Signaling Pathways—KRAS—breast cancer	6.33e-07	1.18e-05	CbGpPWpGaD
Promazine—CYP1A2—Metabolism—PIK3CB—breast cancer	6.29e-07	1.17e-05	CbGpPWpGaD
Promazine—DRD2—Signaling Pathways—TP53—breast cancer	6.28e-07	1.17e-05	CbGpPWpGaD
Promazine—CHRM2—Signaling Pathways—PIK3CA—breast cancer	6.27e-07	1.17e-05	CbGpPWpGaD
Promazine—ADRA1A—Signaling Pathways—PIK3CA—breast cancer	6.26e-07	1.17e-05	CbGpPWpGaD
Promazine—CYP1A2—Metabolism—PTGS2—breast cancer	6.24e-07	1.16e-05	CbGpPWpGaD
Promazine—ADRA1B—Signaling Pathways—IL6—breast cancer	6.24e-07	1.16e-05	CbGpPWpGaD
Promazine—CHRM3—Metabolism—AKT1—breast cancer	6.19e-07	1.15e-05	CbGpPWpGaD
Promazine—HTR2A—Signaling Pathways—TP53—breast cancer	6.18e-07	1.15e-05	CbGpPWpGaD
Promazine—HRH1—Signaling Pathways—TP53—breast cancer	6.17e-07	1.15e-05	CbGpPWpGaD
Promazine—CHRM1—Signaling Pathways—TP53—breast cancer	6.15e-07	1.15e-05	CbGpPWpGaD
Promazine—CHRM3—Signaling Pathways—TP53—breast cancer	6.13e-07	1.14e-05	CbGpPWpGaD
Promazine—CHRM2—Signaling Pathways—TP53—breast cancer	6.07e-07	1.13e-05	CbGpPWpGaD
Promazine—ADRA1A—Signaling Pathways—TP53—breast cancer	6.05e-07	1.13e-05	CbGpPWpGaD
Promazine—HTR2C—Signaling Pathways—AKT1—breast cancer	6.01e-07	1.12e-05	CbGpPWpGaD
Promazine—DRD2—Signaling Pathways—HRAS—breast cancer	6.01e-07	1.12e-05	CbGpPWpGaD
Promazine—HTR2A—Signaling Pathways—HRAS—breast cancer	5.91e-07	1.1e-05	CbGpPWpGaD
Promazine—HRH1—Signaling Pathways—HRAS—breast cancer	5.9e-07	1.1e-05	CbGpPWpGaD
Promazine—CHRM1—Signaling Pathways—HRAS—breast cancer	5.88e-07	1.1e-05	CbGpPWpGaD
Promazine—CHRM3—Signaling Pathways—HRAS—breast cancer	5.86e-07	1.09e-05	CbGpPWpGaD
Promazine—ADRA2A—Signaling Pathways—PIK3CA—breast cancer	5.81e-07	1.08e-05	CbGpPWpGaD
Promazine—CHRM2—Signaling Pathways—HRAS—breast cancer	5.8e-07	1.08e-05	CbGpPWpGaD
Promazine—ADRA1A—Signaling Pathways—HRAS—breast cancer	5.79e-07	1.08e-05	CbGpPWpGaD
Promazine—ADRA1B—Signaling Pathways—AKT1—breast cancer	5.75e-07	1.07e-05	CbGpPWpGaD
Promazine—DRD2—Signaling Pathways—IL6—breast cancer	5.75e-07	1.07e-05	CbGpPWpGaD
Promazine—ADRA2A—Metabolism—AKT1—breast cancer	5.68e-07	1.06e-05	CbGpPWpGaD
Promazine—HTR2A—Signaling Pathways—IL6—breast cancer	5.66e-07	1.05e-05	CbGpPWpGaD
Promazine—HRH1—Signaling Pathways—IL6—breast cancer	5.64e-07	1.05e-05	CbGpPWpGaD
Promazine—CHRM1—Signaling Pathways—IL6—breast cancer	5.63e-07	1.05e-05	CbGpPWpGaD
Promazine—ADRA2A—Signaling Pathways—TP53—breast cancer	5.62e-07	1.05e-05	CbGpPWpGaD
Promazine—CHRM3—Signaling Pathways—IL6—breast cancer	5.61e-07	1.05e-05	CbGpPWpGaD
Promazine—CYP3A4—Metabolism—PIK3CD—breast cancer	5.57e-07	1.04e-05	CbGpPWpGaD
Promazine—CHRM2—Signaling Pathways—IL6—breast cancer	5.55e-07	1.04e-05	CbGpPWpGaD
Promazine—ADRA1A—Signaling Pathways—IL6—breast cancer	5.54e-07	1.03e-05	CbGpPWpGaD
Promazine—CYP3A4—Metabolism—ALB—breast cancer	5.5e-07	1.03e-05	CbGpPWpGaD
Promazine—CYP1A2—Metabolism—PTEN—breast cancer	5.44e-07	1.01e-05	CbGpPWpGaD
Promazine—ADRA2A—Signaling Pathways—HRAS—breast cancer	5.38e-07	1e-05	CbGpPWpGaD
Promazine—DRD2—Signaling Pathways—AKT1—breast cancer	5.3e-07	9.89e-06	CbGpPWpGaD
Promazine—CYP3A4—Metabolism—NOS3—breast cancer	5.26e-07	9.81e-06	CbGpPWpGaD
Promazine—HTR2A—Signaling Pathways—AKT1—breast cancer	5.22e-07	9.73e-06	CbGpPWpGaD
Promazine—HRH1—Signaling Pathways—AKT1—breast cancer	5.21e-07	9.71e-06	CbGpPWpGaD
Promazine—CHRM1—Signaling Pathways—AKT1—breast cancer	5.19e-07	9.68e-06	CbGpPWpGaD
Promazine—CHRM3—Signaling Pathways—AKT1—breast cancer	5.17e-07	9.65e-06	CbGpPWpGaD
Promazine—ADRA2A—Signaling Pathways—IL6—breast cancer	5.15e-07	9.6e-06	CbGpPWpGaD
Promazine—CHRM2—Signaling Pathways—AKT1—breast cancer	5.12e-07	9.56e-06	CbGpPWpGaD
Promazine—ADRA1A—Signaling Pathways—AKT1—breast cancer	5.11e-07	9.53e-06	CbGpPWpGaD
Promazine—CYP2C19—Metabolism—PIK3CA—breast cancer	4.92e-07	9.18e-06	CbGpPWpGaD
Promazine—CYP3A4—Metabolism—PIK3CB—breast cancer	4.86e-07	9.06e-06	CbGpPWpGaD
Promazine—CYP3A4—Metabolism—PTGS2—breast cancer	4.81e-07	8.98e-06	CbGpPWpGaD
Promazine—ADRA2A—Signaling Pathways—AKT1—breast cancer	4.75e-07	8.85e-06	CbGpPWpGaD
Promazine—CYP2C9—Metabolism—PIK3CA—breast cancer	4.49e-07	8.37e-06	CbGpPWpGaD
Promazine—CYP3A4—Metabolism—PTEN—breast cancer	4.2e-07	7.83e-06	CbGpPWpGaD
Promazine—CYP2C19—Metabolism—AKT1—breast cancer	4.02e-07	7.5e-06	CbGpPWpGaD
Promazine—CYP1A2—Metabolism—PIK3CA—breast cancer	3.84e-07	7.16e-06	CbGpPWpGaD
Promazine—CYP2C9—Metabolism—AKT1—breast cancer	3.67e-07	6.84e-06	CbGpPWpGaD
Promazine—CYP1A2—Metabolism—AKT1—breast cancer	3.13e-07	5.85e-06	CbGpPWpGaD
Promazine—CYP3A4—Metabolism—PIK3CA—breast cancer	2.96e-07	5.52e-06	CbGpPWpGaD
Promazine—CYP3A4—Metabolism—AKT1—breast cancer	2.42e-07	4.51e-06	CbGpPWpGaD
